162 related articles for article (PubMed ID: 32803354)
1. Characteristics of hospitalized dermatomyositis patients with underlying malignancy: a nationally representative retrospective cohort study.
Tripathi R; Fernandez AP
Arch Dermatol Res; 2021 Aug; 313(6):473-482. PubMed ID: 32803354
[TBL] [Abstract][Full Text] [Related]
2. An 11-year review of dermatomyositis in Asian patients.
Liu WC; Ho M; Koh WP; Tan AW; Ng PP; Chua SH; Tan SH; Tang MB
Ann Acad Med Singap; 2010 Nov; 39(11):843-7. PubMed ID: 21165524
[TBL] [Abstract][Full Text] [Related]
3. Inpatient burden and resource utilization of polymyositis and dermatomyositis: A 10-year Study of National Inpatient Sample.
Ungprasert P; Wannarong T; Cheungpasitporn W; Wijarnpreecha K; Thongprayoon C; Kroner PT
Joint Bone Spine; 2020 Jul; 87(4):327-330. PubMed ID: 32184181
[TBL] [Abstract][Full Text] [Related]
4. Malignancy in a retrospective cohort of 17 patients with Dermatomyositis or Polymyositis in southern Tunisia.
Sellami K; Mseddi M; Snoussi M; Gharbi H; Frikha F; Salah RB; Jallouli M; Marzouk S; Masmoudi A; Bahloul Z; Turki H
Rom J Intern Med; 2018 Dec; 56(4):243-249. PubMed ID: 29791319
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Hospitalization, Length of Stay, and Cost of Care Among Adults With Dermatomyositis in the United States.
Kwa MC; Ardalan K; Laumann AE; Silverberg JI
Arthritis Care Res (Hoboken); 2017 Sep; 69(9):1391-1399. PubMed ID: 28556622
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis.
Fardet L; Dupuy A; Gain M; Kettaneh A; Chérin P; Bachelez H; Dubertret L; Lebbe C; Morel P; Rybojad M
Medicine (Baltimore); 2009 Mar; 88(2):91-97. PubMed ID: 19282699
[TBL] [Abstract][Full Text] [Related]
7. Classical and amyopathic dermatomyositis seen at the National Skin Centre of Singapore: a 3-year retrospective review of their clinical characteristics and association with malignancy.
Ang P; Sugeng MW; Chua SH
Ann Acad Med Singap; 2000 Mar; 29(2):219-23. PubMed ID: 10895343
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in dermatomyositis: a systematic review of the literature.
Di Rollo D; Abeni D; Tracanna M; Capo A; Amerio P
G Ital Dermatol Venereol; 2014 Oct; 149(5):525-37. PubMed ID: 24975953
[TBL] [Abstract][Full Text] [Related]
9. Inpatient burden of juvenile dermatomyositis among children in the United States.
Kwa MC; Silverberg JI; Ardalan K
Pediatr Rheumatol Online J; 2018 Nov; 16(1):70. PubMed ID: 30424778
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
[TBL] [Abstract][Full Text] [Related]
11. Incidence of malignancies in biopsy-proven inflammatory myopathy.
Kannan MA; Sundaram C; Uppin M; Mridula R; Jabeen SA; Borgohain R
Neurol India; 2013; 61(2):152-5. PubMed ID: 23644314
[TBL] [Abstract][Full Text] [Related]
12. Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: A retrospective case-control study.
Wu C; Wang Q; He L; Yang E; Zeng X
PLoS One; 2018; 13(2):e0192491. PubMed ID: 29474373
[TBL] [Abstract][Full Text] [Related]
13. Incidence and predictive factors for malignancies with dermatomyositis: a cohort from southern China.
Chen D; Yuan S; Wu X; Li H; Qiu Q; Zhan Z; Ye Y; Lian F; Liang L; Xu H; Yang X
Clin Exp Rheumatol; 2014; 32(5):615-21. PubMed ID: 25068842
[TBL] [Abstract][Full Text] [Related]
14. National Burden of Hospitalization Due to Cutaneous Melanoma in Adolescents and Young Adults.
Tripathi R; Knusel KD; Ezaldein HH; Bordeaux JS; Scott JF
Am J Clin Oncol; 2019 Nov; 42(11):830-836. PubMed ID: 31569167
[TBL] [Abstract][Full Text] [Related]
15. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study.
Chen YJ; Wu CY; Shen JL
Br J Dermatol; 2001 Apr; 144(4):825-31. PubMed ID: 11298544
[TBL] [Abstract][Full Text] [Related]
16. Dermatomyositis and malignancy in Tunisia: a multicenter national retrospective study of 20 cases.
Mebazâa A; Boussen H; Nouira R; Rokbani L; Ben Osman-Dhahri A; Bouaouina N; Laouani-Kechrid C; Louzir B; Zahaf A; Kamoun MR
J Am Acad Dermatol; 2003 Apr; 48(4):530-4. PubMed ID: 12664015
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis.
So MW; Koo BS; Kim YG; Lee CK; Yoo B
J Rheumatol; 2011 Nov; 38(11):2432-5. PubMed ID: 21844145
[TBL] [Abstract][Full Text] [Related]
18. Risk of Malignancy in Dermatomyositis and Polymyositis.
Qiang JK; Kim WB; Baibergenova A; Alhusayen R
J Cutan Med Surg; 2017; 21(2):131-136. PubMed ID: 27534779
[TBL] [Abstract][Full Text] [Related]
19. Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan.
Hsu JL; Liao MF; Chu CC; Kuo HC; Lyu RK; Chang HS; Chen CM; Wu YR; Chang KH; Weng YC; Chang CW; Chiang HI; Cheng CK; Lee PW; Huang CC; Ro LS
Sci Rep; 2021 Feb; 11(1):4545. PubMed ID: 33633147
[TBL] [Abstract][Full Text] [Related]
20. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study.
Stockton D; Doherty VR; Brewster DH
Br J Cancer; 2001 Jul; 85(1):41-5. PubMed ID: 11437400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
